$TFX (Teleflex Incorporated)

$TFX {{ '2016-03-11T11:51:43+0000' | timeago}} • Announcement

$TFX reported worldwide recall of ARROW Catheter Kits and Percutaneous Insertion Kits, as per US FDA a Class I recall. The kits are being recalled as the sheath body may become separated from the sheath hub, which can cause patients to bleed. At the time of recall, 13 adverse events were reported including 6 serious injuries and 1 death.

$TFX {{ '2017-05-15T11:14:58+0000' | timeago}} • Announcement

$TFX commenced the Phase I clinical study of RePlas, a lyophilized fresh frozen plasma product being developed in collaboration with the U.S. Army Medical Materiel Development Activity (USAMMDA). The early administration of plasma has an important role in reducing trauma mortality from uncontrolled bleeding (hemorrhage).

$TFX {{ '2017-05-08T12:46:37+0000' | timeago}} • Announcement

$TFX's BoD declared a quarterly cash dividend of $0.34 per share of common stock. The dividend is payable on June 15, 2017 to shareholders of record at the close of business on May 15, 2017.

$TFX {{ '2017-05-02T14:03:12+0000' | timeago}} • Announcement

$TFX announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its AC3 Optimus Intra-Aortic Balloon Pump (IABP). This device helps a weakened heart pump blood and can deliver IABP therapy to a broad range of patients, even those not previously considered candidates for IABP therapy.

$TFX {{ '2017-04-04T15:08:12+0000' | timeago}} • Announcement

Teleflex Medical Canada Inc., a unit of $TFX, has completed the acquisition of Pyng Medical Corp. Under the terms of the transaction, Pyng shareholders received US$0.302 in cash per common share. Pyng is now wholly-owned by Teleflex Canada.

$TFX {{ '2017-02-23T15:04:46+0000' | timeago}} • Announcement

$TFX's BoD declared a quarterly cash dividend of $0.34 per share of common stock. The dividend is payable on March 15, 2017 to shareholders of record on March 3, 2017.

$TFX {{ '2017-02-23T15:02:08+0000' | timeago}} • Announcement

$TFX said Benson Smith will retire from his position as CEO, effective on Dec. 31, 2017. Smith will continue to serve as its Chairman of the Board. Smith has been nominated to serve for another 3-year term if elected at 2017 annual meeting. Liam Kelly, who now serves as President and COO, will succeed Smith as CEO following his retirement.

$TFX {{ '2017-02-17T18:28:33+0000' | timeago}} • Announcement

$TFX completed its previously announced acquisition of $VASC. On Dec. 2, 2016, the two companies announced a definitive agreement for $TFX to buy all of the issued and outstanding shares of $VASC common stock for $56.00 per share, in cash.

$PGNX {{ '2017-02-16T14:24:33+0000' | timeago}} • Announcement

$PGNX will replace $CLMS in the S&P SmallCap 600 effective Feb. 21, 2017 as $CLMS is being taken private in a transaction expected to be completed soon. $SFLY will replace $VASC in the S&P SmallCap 600 effective Feb. 21, 2017, as $VASC is being acquired by $TFX.

$TFX {{ '2016-12-14T13:37:36+0000' | timeago}} • Announcement

$TFX acquisition of $VASC is currently being investigated by WeissLaw LLP, said $VASC. Ongoing investigation is on the possible breaches of fiduciary duty and other violations of law by $VASC's BoD in connection with the acquisition. Under the terms of agreement, $VASC shareholders will receive $56.00 in cash for each company's share.

$VASC {{ '2016-12-02T14:23:03+0000' | timeago}} • Announcement

$VASC agreed to be acquired by $TFX for purchase price of $56 per share in cash. The transaction implies an equity purchase price of $1Bil. The price is 38.4x the midpoint of preliminary 2017 EPS forecast of $1.44-1.48 and transaction value is 5.2x midpoint of preliminary 2017 revenue forecast of $183-187MM. The deal will close in 1H17.

$TFX {{ '2016-12-02T13:12:02+0000' | timeago}} • Announcement

$TFX acquires $VASC. The transaction is expected to create value for $TFX shareholders and to be accretive to adjusted EPS in 2017, including the impact of incremental interest expense associated with financing the transaction. $TFX expects the acquisition to provide approx. $0.50 in adjusted EPS accretion in FY18.

$TFX {{ '2016-12-02T13:08:40+0000' | timeago}} • Announcement

$TFX acquires $VASC for approx. $1Bil. Under the terms of the agreement, $TFX will acquire all of the issued and outstanding shares of $VASC common stock for $56 per share in cash. The transaction is expected to close during 1H17.

$TFX {{ '2016-10-28T19:19:56+0000' | timeago}} • Announcement

$TFX said that its BoD declared a quarterly cash dividend of $0.34 per share of common stock. The dividend is payable Dec. 15, 2016 to shareholders of record at the close of business on Nov. 15, 2016.

$TFX {{ '2016-10-26T20:24:40+0000' | timeago}} • Webcast

$TFX said its Arrow VPS Rhythm System has been issued CE certification from its notified body, the British Standards Institution (BSI), to commercialize the device in the European Union. The CE mark for the system brings cost-effective catheter navigation and tip confirmation to Europe.

$TFX {{ '2016-10-17T11:36:58+0000' | timeago}} • Announcement

Medical device maker $TFX received FDA clearance to market its Arrow branded midline catheter with Chlorag ard technology. Catheter is a flexible tube inserted through a narrow opening into a body cavity, particularly the bladder, for removing fluid.

$TFX {{ '2016-07-29T05:30:37+0000' | timeago}} • Announcement

$TFX said its BoD declared a quarterly cash dividend of $0.34 per common share. The dividend is payable Sept. 15, 2016 to shareholders of record at the close of business on Aug. 15, 2016.

$TFX {{ '2016-05-02T13:34:47+0000' | timeago}} • Announcement

$TFX, a provider of medical technology products, said that its BoD declared a quarterly dividend of $0.34 per share. This cash dividend is payable June 15, 2016 to shareholders of record on May 16, 2016.

$TFX {{ '2016-03-17T20:44:31+0000' | timeago}} • Announcement

$TFX has also entered into agreements with dealers party to certain convertible note hedge transactions related to the Notes to unwind a corresponding portion of such convertible note hedge transactions. $TFX has also entered into agreements with such dealer counterparties to unwind certain warrant transactions.

$TFX {{ '2016-03-17T20:43:58+0000' | timeago}} • Announcement

$TFX said it plans to fund principal amount of the exchange consideration through borrowings under its revolving credit agreement. Following the exchanges, which are expected to close on or about April 4, 2016, $136.2MM of the Notes will remain outstanding.

$TFX {{ '2016-03-17T20:43:05+0000' | timeago}} • Announcement

$TFX said it has entered into separate, privately negotiated agreements with certain of the holders of its 3.875% convertible senior subordinated notes due 2017. $TFX has agreed to exchange $219.2MM of the Notes for cash in an amount equal to $1,000 per $1,000 of Notes.

Recent Transcripts

ISRG (Intuitive Surgical, Inc.)
Thursday, July 20 2017 - 8:30pm
ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
CMD (Cantel Medical Corp.)
Thursday, June 8 2017 - 3:00pm
MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
PTX (Pernix Therapeutics Holdings, Inc.)
Monday, May 15 2017 - 8:30pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
OPK (Opko Health, Inc.)
Tuesday, May 9 2017 - 8:30pm
XRAY (DENTSPLY International Inc.)
Tuesday, May 9 2017 - 12:30pm
ENDP (Endo International plc)
Tuesday, May 9 2017 - 12:30pm
HAE (Haemonetics Corporation)
Monday, May 8 2017 - 12:00pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 9:00pm
PCRX (Pacira Pharmaceuticals, Inc.)
Thursday, May 4 2017 - 12:30pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 12:00pm
TFX (Teleflex Incorporated)
Thursday, May 4 2017 - 12:00pm
GMED (Globus Medical, Inc.)
Wednesday, May 3 2017 - 9:30pm
MASI (Masimo Corporation)
Wednesday, May 3 2017 - 8:30pm
LIVN (LivaNova PLC)
Wednesday, May 3 2017 - 1:00pm
AME (Ametek Inc.)
Tuesday, May 2 2017 - 12:30pm
HRC (Hill-Rom Holdings, Inc.)
Friday, April 28 2017 - 12:30pm
RMD (ResMed Inc.)
Thursday, April 27 2017 - 8:30pm

AlphaGraphics you may like